We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+6.6%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$29.1B
AUM Growth
+$628M
(+2.2%)
Cap. Flow
-$702M
Cap. Flow
% of AUM
-2.41%
Top 10 Holdings %
Top 10 Hldgs %
22.73%
Holding
1,138
New
91
Increased
498
Reduced
344
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$407M |
| 2 |
DexCom
DXCM
|
+$326M |
| 3 |
Roper Technologies
ROP
|
+$288M |
| 4 |
PayPal
PYPL
|
+$238M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$498M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$448M |
| 3 |
Fastenal
FAST
|
+$296M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$175M |
| 5 |
Amazon
AMZN
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.26% |
| 2 | Healthcare | 14.35% |
| 3 | Financials | 13.74% |
| 4 | Consumer Discretionary | 12.34% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Johnson & Johnson
JNJ
$641B
| $158M | 0.54% |
1,340,440
+24,678
| +2% | +$2.99M |
|
52
Under Armour
UAA
$3.02B
| $150M | 0.52% |
3,879,353
-263,797
| -6% | -$10.7M |
|
53
Accenture
ACN
$94.3B
| $150M | 0.52% |
1,226,325
-6,201
| -0.5% | -$706K |
|
54
Walt Disney
DIS
$168B
| $140M | 0.48% |
1,511,787
+24,914
| +2% | +$2.39M |
|
55
iShares Core S&P 500 ETF
IVV
$869B
| $135M | 0.47% |
621,882
+80,999
| +15% | +$17.6M |
|
56
Merck
MRK
$323B
| $131M | 0.45% |
2,195,809
-52,013
| -2% | -$3.04M |
|
57
GE Aerospace
GE
$375B
| $130M | 0.45% |
914,807
+4,114
| +0.5% | +$614K |
|
58
Ameriprise Financial
AMP
$47.6B
| $129M | 0.44% |
1,292,606
-25,844
| -2% | -$2.5M |
|
59
Occidental Petroleum
OXY
$54.6B
| $122M | 0.42% |
1,668,712
-23,021
| -1% | -$1.72M |
|
60
TJX Companies
TJX
$173B
| $119M | 0.41% |
3,185,884
+41,678
| +1% | +$1.63M |
|
|
YHOO
61
DELISTED
Yahoo Inc
YHOO
| $116M | 0.4% |
2,687,007
-663,511
| -20% | -$27.2M |
|
62
PepsiCo
PEP
$191B
| $112M | 0.39% |
1,030,259
-3,820
| -0.4% | -$412K |
|
63
RTX Corp
RTX
$294B
| $108M | 0.37% |
1,681,747
-8,232
| -0.5% | -$546K |
|
64
T. Rowe Price
TROW
$25.5B
| $107M | 0.37% |
1,606,572
-37,416
| -2% | -$2.61M |
|
|
DD
65
DELISTED
Du Pont De Nemours E I
DD
| $97.9M | 0.34% |
1,461,329
-1,645
| -0.1% | -$112K |
|
66
Procter & Gamble
PG
$346B
| $95.9M | 0.33% |
1,068,568
+10,643
| +1% | +$924K |
|
67
United Rentals
URI
$70.2B
| $95M | 0.33% |
1,209,936
-174,332
| -13% | -$13.4M |
|
68
Broadridge
BR
$17.7B
| $87.8M | 0.3% |
1,294,666
-54,385
| -4% | -$3.71M |
|
|
AET
69
DELISTED
Aetna Inc
AET
| $86.3M | 0.3% |
747,447
+134,932
| +22% | +$15.8M |
|
|
WCN
70
Waste Connections
WCN
$42.7B
| $85.1M | 0.29% |
1,709,295
+116,535
| +7% | +$5.88M |
|
71
General Dynamics
GD
$105B
| $84.4M | 0.29% |
543,758
+61,302
| +13% | +$9.14M |
|
72
UnitedHealth
UNH
$379B
| $84.1M | 0.29% |
600,664
+63,363
| +12% | +$8.87M |
|
73
W.P. Carey
WPC
$17B
| $81.8M | 0.28% |
1,294,456
-117,212
| -8% | -$7.82M |
|
74
Idexx Laboratories
IDXX
$43.9B
| $80.8M | 0.28% |
716,740
-40,952
| -5% | -$4.32M |
|
75
Crown Castle
CCI
$32.4B
| $80.2M | 0.28% |
850,866
+2,521
| +0.3% | +$242K |
|
Similar funds
QCM
Brown Advisory's Q3 2016 Portfolio in Review
As of Q3 2016, Brown Advisory held 1,138 positions worth $29.1B, up 2.2% from $28.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Brown Advisory's Q3 2016 filing shows 91 new, 498 increased, 344 reduced and 68 closed positions. Its largest new stake was Fortive: 12,666,674 shares worth $407M. The largest sale was Bristol-Myers Squibb, an estimated $498M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q3 2016 buy was Fortive: 12,666,674 shares worth $407M.
- Brown Advisory added most to DexCom in Q3 2016, an estimated $326M increase.
- Brown Advisory's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $498M.
- Brown Advisory fully exited DIAMOND RESORTS INTL, INC in Q3 2016, selling an estimated $53.1M.
- Brown Advisory's ten largest holdings make up 23% of its $29.1B portfolio in Q3 2016.
- Brown Advisory opened 91 new positions and closed 68 in Q3 2016.
- Brown Advisory's portfolio value rose 2.2% quarter-over-quarter to $29.1B.
Based on Brown Advisory's 13F filing for Q3 2016, filed 14 Nov 2016.